Kirk AD - Search Results

1

Belatacept and sirolimus prolong nonhuman primate islet allograft survival: adverse consequences of concomitant alefacept therapy.

Lowe MC, Badell IR, Turner AP, Thompson PW, Leopardi FV, Strobert EA, Larsen CP, Kirk AD. Lowe MC, et al. Among authors: kirk ad. Am J Transplant. 2013 Feb;13(2):312-9. doi: 10.1111/j.1600-6143.2012.04341.x. Epub 2012 Dec 27. Am J Transplant. 2013. PMID: 23279640 Free PMC article.

2

Efficacy and toxicity of a protocol using sirolimus, tacrolimus and daclizumab in a nonhuman primate renal allotransplant model.

Montgomery SP, Mog SR, Xu H, Tadaki DK, Hirshberg B, Berning JD, Leconte J, Harlan DM, Hale D, Kirk AD. Montgomery SP, et al. Among authors: kirk ad. Am J Transplant. 2002 Apr;2(4):381-5. doi: 10.1034/j.1600-6143.2002.20415.x. Am J Transplant. 2002. PMID: 12118862 Free article.

3

Rabbit antithymocyte globulin induction and sirolimus monotherapy supports prolonged islet allograft function in a nonhuman primate islet transplantation model.

Hirshberg B, Preston EH, Xu H, Tal MG, Neeman Z, Bunnell D, Soleimanpour S, Hale DA, Kirk AD, Harlan DM. Hirshberg B, et al. Among authors: kirk ad. Transplantation. 2003 Jul 15;76(1):55-60. doi: 10.1097/01.TP.0000068899.48252.1D. Transplantation. 2003. PMID: 12865786

4

Effects of combined treatment with CD25- and CD154-specific monoclonal antibodies in non-human primate allotransplantation.

Xu H, Elster EA, Blair PJ, Burkly LC, Tadaki DK, Harlan DM, Kirk AD. Xu H, et al. Among authors: kirk ad. Am J Transplant. 2003 Nov;3(11):1350-4. doi: 10.1046/j.1600-6135.2003.00235.x. Am J Transplant. 2003. PMID: 14525594 Free article.

5

IDEC-131 (anti-CD154), sirolimus and donor-specific transfusion facilitate operational tolerance in non-human primates.

Preston EH, Xu H, Dhanireddy KK, Pearl JP, Leopardi FV, Starost MF, Hale DA, Kirk AD. Preston EH, et al. Among authors: kirk ad. Am J Transplant. 2005 May;5(5):1032-41. doi: 10.1111/j.1600-6143.2005.00796.x. Am J Transplant. 2005. PMID: 15816883 Free article.

6

Transplant tolerance: converging on a moving target.

Newell KA, Larsen CP, Kirk AD. Newell KA, et al. Among authors: kirk ad. Transplantation. 2006 Jan 15;81(1):1-6. doi: 10.1097/01.tp.0000179149.12979.13. Transplantation. 2006. PMID: 16421467 Review.

7

A new look at blockade of T-cell costimulation: a therapeutic strategy for long-term maintenance immunosuppression.

Larsen CP, Knechtle SJ, Adams A, Pearson T, Kirk AD. Larsen CP, et al. Among authors: kirk ad. Am J Transplant. 2006 May;6(5 Pt 1):876-83. doi: 10.1111/j.1600-6143.2006.01259.x. Am J Transplant. 2006. PMID: 16611323 Free article. Review.

8

CD154 blockade, sirolimus, and donor-specific transfusion prevents renal allograft rejection in cynomolgus monkeys despite homeostatic T-cell activation.

Pearl JP, Xu H, Leopardi F, Preston E, Kirk AD. Pearl JP, et al. Among authors: kirk ad. Transplantation. 2007 May 15;83(9):1219-25. doi: 10.1097/01.tp.0000259929.04596.d5. Transplantation. 2007. PMID: 17496539

9

Dissociation of depletional induction and posttransplant lymphoproliferative disease in kidney recipients treated with alemtuzumab.

Kirk AD, Cherikh WS, Ring M, Burke G, Kaufman D, Knechtle SJ, Potdar S, Shapiro R, Dharnidharka VR, Kauffman HM. Kirk AD, et al. Am J Transplant. 2007 Nov;7(11):2619-25. doi: 10.1111/j.1600-6143.2007.01972.x. Epub 2007 Sep 14. Am J Transplant. 2007. PMID: 17868060 Free PMC article.

10

Alemtuzumab.

Weaver TA, Kirk AD. Weaver TA, et al. Among authors: kirk ad. Transplantation. 2007 Dec 27;84(12):1545-7. doi: 10.1097/01.tp.0000296680.75175.67. Transplantation. 2007. PMID: 18165760

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

334 results

Search Page

Filters